Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5246-5253
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5246
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5246
Characteristic | Group 1 | Group 2 | Group 3 | P value |
No complication | Pre-discharge complication | Post-discharge complication | ||
n = 2497 (55.70) | n = 1588 (35.42) | n = 398 (8.88) | ||
Age, mean (median) | 62.5 ± 11.2 (63) | 63.9 ± 10.8 (65) | 63.4 ± 10.9 (64) | 0.001 |
Age group (yr) | 0.048 | |||
< 60 | 921 (36.88) | 513 (32.30) | 143 (35.93) | |
60-69 | 862 (34.52) | 579 (36.46) | 126 (31.66) | |
70-79 | 602 (24.11) | 407 (25.63) | 109 (27.39) | |
≥ 80 | 112 (4.49) | 89 (5.60) | 20 (5.03) | |
Male1 | 2042 (81.88) | 1220 (76.83) | 325 (81.66) | < 0.001 |
Race | 0.088 | |||
White | 2135 (85.50) | 1363 (85.83) | 352 (88.44) | |
Black | 76 (3.04) | 62 (3.90) | 6 (1.51) | |
Other/unknown | 286 (11.45) | 168 (10.26) | 40 (10.05) | |
ASA classification1 | < 0.001 | |||
No disturb/mild disturb | 611 (24.50) | 237 (14.92) | 88 (22.17) | |
Serious disturb | 1746 (70.01) | 1161 (73.11) | 269 (67.76) | |
Life threat/moribund | 137 (5.49) | 190 (11.96) | 40 (10.08) | |
Body mass index, mean (median) | 27.9 ± 6.4 (27) | 27.7 ± 6.3 (26.9) | 28.4 ± 6.2 (27.6) | 0.132 |
Body mass index group1 (kg/m2) | 0.013 | |||
< 18.5 | 68 (2.75) | 59 (3.75) | 9 (2.26) | |
18.5-24.9 | 761 (30.72) | 522 (33.14) | 100 (25.13) | |
25-29.9 | 905 (36.54) | 532 (33.78) | 159 (39.95) | |
≥ 30 | 743 (30.00) | 462 (29.33) | 130 (32.66) | |
Diabetes | 341 (13.66) | 300 (18.89) | 75 (18.84) | < 0.001 |
Current smoker | 616 (24.67) | 434 (27.33) | 86 (21.61) | 0.033 |
Dyspnea | 209 (8.37) | 205 (12.91) | 48 (12.06) | < 0.001 |
History of COPD | 131 (5.25) | 156 (9.82) | 23 (5.78) | < 0.001 |
Weight loss | 468 (18.74) | 301 (18.95) | 73 (18.34) | 0.959 |
Steroid use | 74 (2.96) | 42 (2.64) | 12 (3.02) | 0.820 |
Emergency case | 18 (0.72) | 39 (2.46) | 3 (0.75) | < 0.001 |
Diagnosis | 0.002 | |||
Benign disease | 355 (14.22) | 289 (18.20) | 56 (14.07) | |
Esophageal/gastric cancer | 2142 (85.78) | 1299 (81.80) | 342 (85.93) | |
Year of operation | 0.012 | |||
2005-2007 | 293 (11.73) | 223 (14.04) | 41 (10.30) | |
2008-2010 | 746 (29.88) | 409 (25.76) | 109 (27.39) | |
2011-2013 | 1458 (58.39) | 956 (60.20) | 248 (62.31) |
Outcome | Total (n = 1986) | Group 2 | Group 3 | P value |
Pre-discharge complication | Post-discharge complication | |||
n = 1588 (79.96) | n = 398 (20.04) | |||
30-d mortality1 | 140 (7.05) | 104 (6.55) | 36 (9.05) | 0.082 |
Overall morbidity | ||||
Wound infection | 470 (23.67) | 307 (19.33) | 163 (40.95) | < 0.001 |
Pneumonia | 535 (26.94) | 444 (27.96) | 91 (22.86) | 0.040 |
Urinary tract infection | 112 (5.64) | 91 (5.73) | 21 (5.28) | 0.725 |
Venous thromboembolism | 207 (10.42) | 142 (8.94) | 65 (16.33) | < 0.001 |
Cardiac complication | 108 (5.44) | 92 (5.79) | 16 (4.02) | 0.163 |
Shock/sepsis | 518 (26.08) | 422 (26.57) | 96 (24.12) | 0.319 |
Unplanned intubation | 420 (21.15) | 368 (23.17) | 52 (13.07) | < 0.001 |
Bleeding transfusion | 584 (29.41) | 526 (33.12) | 58 (14.57) | < 0.001 |
Renal complication | 59 (2.97) | 50 (3.15) | 9 (2.26) | 0.351 |
On ventilator > 48 h | 439 (22.10) | 396 (24.94) | 43 (10.80) | < 0.001 |
Organ space SSI | 242 (12.19) | 174 (10.96) | 68 (17.09) | 0.001 |
Reoperation 12-13 | 235 (25.97) | 160 (22.38) | 75 (39.47) | < 0.001 |
Serious Morbidity2 | 1102 (55.49) | 901 (56.74) | 201 (50.50) | 0.025 |
Year of operation | 0.142 | |||
2005-2007 | 264 (13.29) | 223 (14.04) | 41 (10.30) | |
2008-2010 | 518 (26.08) | 409 (25.76) | 109 (27.39) | |
2011-2013 | 1204 (60.62) | 956 (60.20) | 248 (62.31) | |
Length of stay, d (median) | 11.7 ± 5.4 (10) | 15.0 ± 6.3 (14) | 10.3 ± 4.3 (9) | < 0.001 |
Prolonged length of stay3 | 765 (38.52) | 707 (44.52) | 58 (14.57) | < 0.001 |
Operative time, min (median) | 342.3 ± 134.7 (328) | 358.6 ± 145.6 (343) | 350.4 ± 133.1 (335.5) | 0.308 |
Prolonged operative time4 | 570 (28.70) | 467 (29.41) | 103 (25.88) | 0.164 |
Readmission 2011-2013 | 226 (19.07) | 62 (6.60) | 164 (66.94) | < 0.001 |
Risk factor | PDC risk (n/total) | RR (95%CI) |
Overall PDC risk | 398/4379 (9.09) | - |
Procedure type | ||
Ivor-Lewis | 196/2219 (8.83) | Ref |
Transhiatal | 115/1261 (9.12) | 1.03 (0.83-1.29) |
3-holes | 66/730 (9.04) | 1.02 (0.78-1.34) |
Intestinal conduit | 21/169 (12.43) | 1.41 (0.92-2.15) |
Age group (%) | ||
< 60 | 143/1562 (9.15) | Ref |
60-69 | 126/1529 (8.24) | 0.90 (0.72-1.13) |
70-79 | 109/1082 (10.07) | 1.10 (0.87-1.39) |
≥ 80 | 20/206 (9.71) | 1.06 (0.68-1.65) |
Male (%) | 325/3505 (9.27) | 1.11 (0.87-1.41) |
Race (%) | ||
White | 352/3763 (9.35) | Ref |
Black | 6/137 (4.38) | 0.46 (0.21-1.00) |
Other/unknown | 40/479 (8.35) | 0.89 (0.65-1.22) |
ASA classification (%) | ||
No disturb/mild disturb | 88/930 (9.46) | Ref |
Serious disturb | 269/3104 (8.67) | 0.92 (0.73-1.15) |
Life threat/moribund | 40/341 (11.73) | 1.24 (0.87-1.76) |
Body mass index (%) | ||
18.5-24.9 | 100/1347 (7.42) | Ref |
< 18.5 | 9/129 (6.98) | 0.94 (0.49-1.81) |
25-29.9 | 159/1561 (10.19) | 1.37 (1.08-1.74) |
≥ 30 | 130/1310 (9.92) | 1.34 (1.04-1.72) |
Diabetes (%) | 75/692 (10.84) | 1.24 (0.98-1.57) |
Current smoker (%) | 86/1111 (7.74) | 0.81 (0.64-1.02) |
Dyspnea (%) | 48/436 (11.01) | 1.24 (0.93-1.65) |
History of COPD (%) | 23/297 (7.74) | 0.84 (0.56-1.26) |
Weight loss (%) | 73/812 (8.99) | 0.99 (0.77-1.26) |
Steroid use (%) | 12/124 (9.68) | 1.07 (0.62-1.84) |
Emergency case | 3/52 (5.77) | 0.63 (0.21-1.90) |
Esophageal/gastric cancer (%) | 342/3707 (9.23) | 1.11 (0.84-1.45) |
Prolonged length of stay1 (%) | 58/938 (6.18) | 0.63 (0.48-0.82) |
Prolonged operative time2 (%) | 103/1087 (9.48) | 1.06 (0.85-1.31) |
- Citation: Chen SY, Molena D, Stem M, Mungo B, Lidor AO. Post-discharge complications after esophagectomy account for high readmission rates. World J Gastroenterol 2016; 22(22): 5246-5253
- URL: https://www.wjgnet.com/1007-9327/full/v22/i22/5246.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i22.5246